Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

Freeport-McMoRan FCX has outperformed the market over the past 5 years by 20.14% on an annualized basis producing an average ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

Fiserv FI has outperformed the market over the past 10 years by 8.27% on an annualized basis producing an average annual ...

Gensurv Robotics, a pioneer in autonomous mobile robotics, has been recognized with Thailand's prestigious 2024 National ...

PG&E PCG has outperformed the market over the past 5 years by 12.89% on an annualized basis producing an average annual ...

Navios Maritime Partners Q3 revenue was $340.8M, below the consensus of $377M; TCE rate rose 7% to $23,591 per day. Angeliki ...

Avalanche's AVAX/USD price has increased 5.66% over the past 24 hours to $24.22, which is in the opposite direction of its ...

In the assessment of 12-month price targets, analysts unveil insights for Netstreit, presenting an average target of $18.56, ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $505.38, along ...

Intapp INTA has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish ...

Builders FirstSource Q3 EPS beats estimates, but lowers FY24 sales guidance due to declining revenues, margins, and profit.